In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Protein Forest Inc.

Division of Bio-Techne Corp.

Latest From Protein Forest Inc.

Start-Up Previews (2/04)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Rediscovering Existing Drugs, features profiles of Ascend Therapeutics Inc., Ocularis Pharma Inc. and Oriel Therapeutics Inc. Plus these Start-Ups Across Health Care: Exagen Diagnostics Inc., Piedmont Pharmaceuticals LLC, Protein Forest Inc., Proteus Biomedical Inc. and Xilas Medical Inc.

Protein Forest Inc.

Protein Forest Inc. has devised a way to improve the throughput of 2D gel electrophoresis, which it believes will give it a significant share of the $500 million market for protein separation and analysis tools, of which 2D gel and protein chip technologies comprise roughly half.

Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bio-Techne Corp.
  • Senior Management
  • Russell Garlick, PhD, CEO
  • Contact Info
  • Protein Forest Inc.
    Phone: (617) 926-4788
    128 Spring Street
    Suite 502
    Lexington, MA 02421